Two bioceramics (Ca–P–O glass and A–W glass ceramic) were produced using conventional methods of ceramic technology. X-ray powder diffraction patterns were used for identifying the phases and 3-point bend test was carried out for the determination of fracture strength of the bioceramics. Biocompatibility of both ceramics was evaluated using animal model experiments. Histological studies showed that A–W glass ceramic implanted in the tibia of rat formed an intimate contact with newly grown bone and provided enough strength to the bone to bear the animal weight. Implants made of Ca–P–O glass was almost fully resorbed and was replaced by new bone. The implants made of both the bioceramics were biocompatible and did not exhibit any kind of adverse effect to the surrounding tissues.

High purity fine silver powder with uniform particle morphology was prepared through glycerol process. The process involves reduction of silver nitrate by glycerol under atmospheric conditions at a temperature below 175°C. Glycerol, in this process, acts as a solvent as well as a reducing agent. The powders prepared through this process were characterized by X-ray diffraction (XRD), scanning electron microscopy (SEM) and chemical analysis. The powders were well crystalline and contained oxygen, carbon and hydrogen as impurities. Overall purity was better than 99.9%. The yield of silver powder was better than 99%.